BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 26101492)

  • 21. Single nucleotide polymorphisms in VEGF gene are associated with an increased risk of osteosarcoma.
    Tie Z; Bai R; Zhai Z; Zhang G; Zhang H; Zhao Z; Zhou D; Liu W
    Int J Clin Exp Pathol; 2014; 7(11):8143-9. PubMed ID: 25550863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of the vascular endothelial growth factor -2578C/A polymorphism with cancer risk: A meta-analysis update.
    Chen Q; Zhou Z; Shan L; Hua Y; Zeng H; Liu P; Cai Z
    Biomed Rep; 2014 Nov; 2(6):823-830. PubMed ID: 25279153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular endothelial growth factor (VEGF) gene polymorphisms and breast cancer risk in Punjabi population from North West India.
    Kapahi R; Guleria K; Sambyal V; Manjari M; Sudan M; Uppal MS; Singh NR
    Tumour Biol; 2014 Nov; 35(11):11171-81. PubMed ID: 25106408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular endothelial growth factor (VEGF) polymorphism and increased risk of epithelial ovarian cancer.
    Rinck-Junior JA; Oliveira C; Lourenço GJ; Sagarra RA; Derchain SF; Segalla JG; Lima CS
    J Cancer Res Clin Oncol; 2015 Jan; 141(1):69-73. PubMed ID: 25092217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteosarcoma.
    Moore DD; Luu HH
    Cancer Treat Res; 2014; 162():65-92. PubMed ID: 25070231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between vascular endothelial growth factor gene polymorphisms and bladder cancer risk.
    Yang Y; Zhang X; Song D; Wei J
    Mol Clin Oncol; 2014 Jul; 2(4):501-505. PubMed ID: 24940484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of the associations between three VEGF polymorphisms and risk of prostate cancer.
    Chen GQ; Luo JB; Wang GZ; Ding JE
    Tumour Biol; 2014 Mar; 35(3):1875-9. PubMed ID: 24353087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of the vascular endothelial growth factor (VEGF) gene single-nucleotide polymorphisms with osteosarcoma susceptibility in a Chinese population.
    Wang Z; Wen P; Luo X; Fang X; Wang Q; Ma F; Lv J
    Tumour Biol; 2014 Apr; 35(4):3605-10. PubMed ID: 24310504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of RECQL5 gene polymorphisms and osteosarcoma in a Chinese Han population.
    Zhi LQ; Ma W; Zhang H; Zeng SX; Chen B
    Tumour Biol; 2014 Apr; 35(4):3255-9. PubMed ID: 24287950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between CTLA-4 genetic polymorphisms and susceptibility to osteosarcoma in Chinese Han population.
    He J; Wang J; Wang D; Dai S; Yv T; Chen P; Ma R; Diao C; Lv G
    Endocrine; 2014 Mar; 45(2):325-30. PubMed ID: 24078408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association analysis between genetic variants of MDM2 gene and osteosarcoma susceptibility in Chinese.
    He J; Wang J; Wang D; Dai S; Yv T; Chen P; Ma R; Diao C; Lv G
    Endocr J; 2013; 60(11):1215-20. PubMed ID: 23933591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A systematic review of vascular endothelial growth factor expression as a biomarker of prognosis in patients with osteosarcoma.
    Chen D; Zhang YJ; Zhu KW; Wang WC
    Tumour Biol; 2013 Jun; 34(3):1895-9. PubMed ID: 23589053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular normalization as an emerging strategy to enhance cancer immunotherapy.
    Huang Y; Goel S; Duda DG; Fukumura D; Jain RK
    Cancer Res; 2013 May; 73(10):2943-8. PubMed ID: 23440426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program.
    Mirabello L; Troisi RJ; Savage SA
    Cancer; 2009 Apr; 115(7):1531-43. PubMed ID: 19197972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteosarcoma: anatomic and histologic variants.
    Klein MJ; Siegal GP
    Am J Clin Pathol; 2006 Apr; 125(4):555-81. PubMed ID: 16627266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple primary malignancies in osteosarcoma patients. Incidence and predictive value of osteosarcoma subtype for cancer syndromes related with osteosarcoma.
    Hauben EI; Arends J; Vandenbroucke JP; van Asperen CJ; Van Marck E; Hogendoorn PC
    Eur J Hum Genet; 2003 Aug; 11(8):611-8. PubMed ID: 12891382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The biology of VEGF and its receptors.
    Ferrara N; Gerber HP; LeCouter J
    Nat Med; 2003 Jun; 9(6):669-76. PubMed ID: 12778165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiogenesis in health and disease.
    Carmeliet P
    Nat Med; 2003 Jun; 9(6):653-60. PubMed ID: 12778163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignant transformation of fibrous dysplasia into chondroblastic osteosarcoma.
    Kaushik S; Smoker WR; Frable WJ
    Skeletal Radiol; 2002 Feb; 31(2):103-6. PubMed ID: 11828332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production.
    Watson CJ; Webb NJ; Bottomley MJ; Brenchley PE
    Cytokine; 2000 Aug; 12(8):1232-5. PubMed ID: 10930302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.